Clorazepate Dipotassium Tablet
Product Images NDC 13107-321

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Clorazepate Dipotassium (NDC 13107-321). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurolife Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Clorazepate Str)

Chemical structure diagram of clorazepate dipotassium, showing its molecular framework with distinctive chlorine, nitrogen, and carbonyl groups and potassium atoms. The diagram illustrates key structural elements relevant to the active ingredient clorazepate dipotassium.*

FDA Label Image

Package Label.principal Display Panel (3.75 mg 100 Tablets Container Label)

Label for Clorazepate Dipotassium Tablets USP 3.75 mg, oral dosage form. The label indicates the product is prescription-only with NDC 13107-319-01, provided in a package of 100 tablets. It advises storage at 20°-25°C and to keep medication out of reach of children. The product is distributed by Aurobindo Pharma USA, Inc., made in Australia, with directions to dispense accompanying medication guide.*

FDA Label Image

Package Label-principal Display Panel (15 mg (100 Tablets Bottle))

Label for Clorazepate Dipotassium Tablets, USP, 7.5 mg. The label indicates Rx only, with a package size of 100 tablets. It includes storage instructions, warnings, and distributor information from Aurobindo Pharma USA, Inc., with the drug made in Australia. The label features the NDC 13107-320-01 and the Aurolife Pharma LLC labeler.*

FDA Label Image

Package Label-principal Display Panel (7.5 mg (100 Tablets Bottle))

Label for Clorazepate Dipotassium Tablets, USP 15 mg, distributed by Aurobindo Pharma USA, Inc., containing 100 tablets. The label includes storage instructions, a warning to keep out of reach of children, and a pharmacist dispense note. The NDC is 13107-321-01. Tablets are made in Australia.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.